Additionally, our findings suggest that neutrophils in myeloma patients engage in aberrant interactions with NK cells via receptors such as HLA-E, which could account for the diminished NK cell presence in the high-risk cohort, consequently affecting prognosis. This evidence concerns the gene HLA-E and plasma cell myeloma.